← FDA DRUG APPROVALS
FDA ANDA · ANDA207399
MILNACIPRAN HYDROCHLORIDE
Sponsor: STRIDES PHARMA GLOBAL PTE LIMITED
APPLICATION
ANDA207399
TYPE
ANDA
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
MILNACIPRAN HYDROCHLORIDENone (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 50MG · TABLET
MILNACIPRAN HYDROCHLORIDENone (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 25MG · TABLET
MILNACIPRAN HYDROCHLORIDENone (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 100MG · TABLET
Approval history
2026-03-09UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.